<?xml version="1.0" encoding="UTF-8" standalone="yes"?><?xml-stylesheet type="text/xsl" href="/oai-pmh-repository/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-10-15T09:45:08Z</responseDate>
    <request verb="GetRecord" identifier="oai:data.mendeley.com/h675frfmsb.1" metadataPrefix="oai_dc">https://data.mendeley.com/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>oai:data.mendeley.com/h675frfmsb.1</identifier>
                <datestamp>2025-11-25T09:51:27Z</datestamp>
            </header>
            <metadata><oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <dc:creator>Bellone, Maria Laura</dc:creator>
    <dc:title>&quot;How different are 2D and 3D in vitro model for investigating the mechanism of action of bioactive compounds? The case of phytocannabinoid CBDA&quot;_3D pulsedSILAC</dc:title>
    <dc:publisher>Mendeley Data</dc:publisher>
    <dc:description>The title of the paper is the following: &quot;How different are 2D and 3D in vitro model for investigating the mechanism of action of
bioactive compounds? The case of phytocannabinoid CBDA&quot;. 
The scope of the present work concerned the investigation of the CBDA-EIF2A interaction in 3D-U87MG cell model. 
For pulsedSILAC, U87MG cells were cultured in 3D-cell model in presence or not of CBDA. Subsequently, protein mixture was obtained and click chemistry reaction was carried out. Then, enzymatic digestion with trypsin and peptide clean-up were performed and the samples underwent to LC-MS/MS analysis. 
Raw files obtained from Orbitrap fusion mass spectrometer were processed with Proteome Discoverer software. Fasta file UP000005640_9606 was set as protein database. The maximum number of missed cleavages was set to 2. Unique peptides were set for quantification.  Quantitative analysis was set as ratio Heavy/Medium.</dc:description>
    <dc:subject>Drug Discovery</dc:subject>
    <dc:subject>Cannabinoid</dc:subject>
    <dc:subject>Interaction Proteomics</dc:subject>
    <dc:contributor>Syed, Azmal Ali</dc:contributor>
    <dc:contributor>Appendino, Giovanni</dc:contributor>
    <dc:contributor>Krijgsveld, Jeroen</dc:contributor>
    <dc:contributor>De Tommasi, Nunziatina</dc:contributor>
    <dc:contributor>Dal Piaz, Fabrizio</dc:contributor>
    <dc:type>Dataset</dc:type>
    <dc:identifier>doi:10.17632/h675frfmsb.1</dc:identifier>
    <dc:identifier>oai:data.mendeley.com/h675frfmsb.1</dc:identifier>
    <dc:rights>Creative Commons Attribution 4.0 International</dc:rights>
    <dc:rights>http://creativecommons.org/licenses/by/4.0</dc:rights>
    <dc:relation>https://data.mendeley.com/datasets/h675frfmsb</dc:relation>
    <dc:date>2025-11-25T09:51:27Z</dc:date>
</oai_dc:dc></metadata>
        </record>
    </GetRecord>
</OAI-PMH>
